Organizational Readiness

This public meeting explored real-world experiences and scientific evidence on emerging data trends for human xylazine exposure and examined concrete strategies for drug development and clinical research.

This toolkit provides clinically relevant information to support high-quality delivery of outpatient OUD care via telehealth, while reducing barriers to starting and maintaining both medication and psychosocial treatments.

This fact sheet provides healthcare providers and people who use drugs with an overview of fentanyl and fentanyl test strips to prevent overdose. Other harm reduction strategies are also provided.

The VA Opioid Overdose Education & Naloxone Distribution (OEND) Program aims to reduce harm and risk of life-threatening opioid-related overdose and deaths among Veterans. This resource hub includes implementation toolkits, patient & provider guides, overdose education & naloxone distribution vidoes, and additional related VA resources.

This fact sheet provides an overview of the Medication First (or low-barrier maintenance pharmacotherapy) approach to the treatment of opioid use disorders.

This issue brief makes implementation recommendations for low-barrier medication for opioid use disorders.

This guide provides information and strategies to primary care providers on harm reduction as a trauma informed approach to treating individuals with substance use disorder.

This resource document provides practical, evidence-based information for primary care providers and practices on prescribing buprenorphine to individuals in need of intervention, including implementation considerations and strategies for primary care providers and primary care organizations.

This guide provides research about language, recommended language and rationale to avoid stigma around substance use, and implementation resources to address stigma in medical facilities.

This sheet provides ideas to tackle stigma and develop an Action Plan to reduce stigma in organizations.